| GO:0005575 |
cellular_component |
12.74% (20/157) |
1.39 |
8.3e-05 |
0.00817 |
| GO:0110165 |
cellular anatomical entity |
10.83% (17/157) |
1.45 |
0.00018 |
0.008912 |
| GO:0003674 |
molecular_function |
32.48% (51/157) |
0.7 |
0.000152 |
0.009057 |
| GO:0008237 |
metallopeptidase activity |
2.55% (4/157) |
3.96 |
0.000134 |
0.009948 |
| GO:0043226 |
organelle |
7.01% (11/157) |
2.08 |
6.8e-05 |
0.010118 |
| GO:0019001 |
guanyl nucleotide binding |
3.82% (6/157) |
2.64 |
0.000437 |
0.01298 |
| GO:0008233 |
peptidase activity |
3.82% (6/157) |
2.64 |
0.000437 |
0.01298 |
| GO:0043169 |
cation binding |
7.01% (11/157) |
1.74 |
0.000525 |
0.012998 |
| GO:0046872 |
metal ion binding |
7.01% (11/157) |
1.74 |
0.000502 |
0.013557 |
| GO:0032561 |
guanyl ribonucleotide binding |
3.82% (6/157) |
2.67 |
0.000389 |
0.01445 |
| GO:0005525 |
GTP binding |
3.82% (6/157) |
2.67 |
0.000389 |
0.01445 |
| GO:0006508 |
proteolysis |
3.82% (6/157) |
2.51 |
0.000717 |
0.016379 |
| GO:0008235 |
metalloexopeptidase activity |
1.27% (2/157) |
5.48 |
0.000906 |
0.017934 |
| GO:0005488 |
binding |
20.38% (32/157) |
0.83 |
0.000847 |
0.017965 |
| GO:0043229 |
intracellular organelle |
7.01% (11/157) |
2.08 |
6.7e-05 |
0.020032 |
| GO:0034645 |
cellular macromolecule biosynthetic process |
5.1% (8/157) |
1.97 |
0.001101 |
0.020431 |
| GO:0046914 |
transition metal ion binding |
4.46% (7/157) |
1.85 |
0.003557 |
0.029348 |
| GO:1901564 |
organonitrogen compound metabolic process |
9.55% (15/157) |
1.14 |
0.003541 |
0.030051 |
| GO:0043167 |
ion binding |
11.46% (18/157) |
1.11 |
0.00183 |
0.030187 |
| GO:0043228 |
non-membrane-bounded organelle |
4.46% (7/157) |
1.85 |
0.003498 |
0.030559 |
| GO:0043232 |
intracellular non-membrane-bounded organelle |
4.46% (7/157) |
1.85 |
0.003498 |
0.030559 |
| GO:0043227 |
membrane-bounded organelle |
2.55% (4/157) |
2.58 |
0.004691 |
0.031664 |
| GO:1901566 |
organonitrogen compound biosynthetic process |
5.1% (8/157) |
1.66 |
0.004065 |
0.03177 |
| GO:0008150 |
biological_process |
18.47% (29/157) |
0.75 |
0.003429 |
0.031824 |
| GO:0008152 |
metabolic process |
14.01% (22/157) |
0.97 |
0.001829 |
0.031956 |
| GO:0098588 |
bounding membrane of organelle |
1.27% (2/157) |
4.3 |
0.004663 |
0.032205 |
| GO:0019538 |
protein metabolic process |
8.28% (13/157) |
1.21 |
0.004494 |
0.032556 |
| GO:0006518 |
peptide metabolic process |
4.46% (7/157) |
1.81 |
0.004058 |
0.03257 |
| GO:0006801 |
superoxide metabolic process |
1.27% (2/157) |
4.53 |
0.003408 |
0.032646 |
| GO:0072593 |
reactive oxygen species metabolic process |
1.27% (2/157) |
4.53 |
0.003408 |
0.032646 |
| GO:0043231 |
intracellular membrane-bounded organelle |
2.55% (4/157) |
2.59 |
0.004618 |
0.032654 |
| GO:0005198 |
structural molecule activity |
4.46% (7/157) |
1.8 |
0.004292 |
0.032689 |
| GO:0043603 |
amide metabolic process |
4.46% (7/157) |
1.79 |
0.004466 |
0.033163 |
| GO:1990837 |
sequence-specific double-stranded DNA binding |
0.64% (1/157) |
7.39 |
0.00596 |
0.034038 |
| GO:0001067 |
transcription regulatory region nucleic acid binding |
0.64% (1/157) |
7.39 |
0.00596 |
0.034038 |
| GO:0000977 |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
0.64% (1/157) |
7.39 |
0.00596 |
0.034038 |
| GO:0032422 |
purine-rich negative regulatory element binding |
0.64% (1/157) |
7.39 |
0.00596 |
0.034038 |
| GO:0000976 |
transcription cis-regulatory region binding |
0.64% (1/157) |
7.39 |
0.00596 |
0.034038 |
| GO:0043604 |
amide biosynthetic process |
4.46% (7/157) |
1.86 |
0.003354 |
0.034349 |
| GO:0044271 |
cellular nitrogen compound biosynthetic process |
5.1% (8/157) |
1.56 |
0.006154 |
0.034487 |
| GO:0043043 |
peptide biosynthetic process |
4.46% (7/157) |
1.87 |
0.00327 |
0.034681 |
| GO:0044260 |
cellular macromolecule metabolic process |
5.1% (8/157) |
1.6 |
0.005301 |
0.034988 |
| GO:0009058 |
biosynthetic process |
6.37% (10/157) |
1.38 |
0.005455 |
0.035222 |
| GO:0003735 |
structural constituent of ribosome |
4.46% (7/157) |
1.87 |
0.003242 |
0.03566 |
| GO:0051082 |
unfolded protein binding |
1.91% (3/157) |
3.53 |
0.0023 |
0.035952 |
| GO:0071704 |
organic substance metabolic process |
12.1% (19/157) |
0.92 |
0.005767 |
0.036444 |
| GO:1901576 |
organic substance biosynthetic process |
6.37% (10/157) |
1.49 |
0.003205 |
0.036615 |
| GO:0044249 |
cellular biosynthetic process |
5.73% (9/157) |
1.42 |
0.0071 |
0.036997 |
| GO:0009059 |
macromolecule biosynthetic process |
5.1% (8/157) |
1.74 |
0.003019 |
0.037356 |
| GO:0044238 |
primary metabolic process |
11.46% (18/157) |
0.92 |
0.007074 |
0.037515 |
| GO:0006412 |
translation |
4.46% (7/157) |
1.88 |
0.00316 |
0.037536 |
| GO:0008238 |
exopeptidase activity |
1.27% (2/157) |
4.0 |
0.007045 |
0.038045 |
| GO:0003746 |
translation elongation factor activity |
1.27% (2/157) |
4.0 |
0.007045 |
0.038045 |
| GO:0005765 |
lysosomal membrane |
0.64% (1/157) |
8.39 |
0.002984 |
0.038535 |
| GO:0005774 |
vacuolar membrane |
0.64% (1/157) |
8.39 |
0.002984 |
0.038535 |
| GO:0098852 |
lytic vacuole membrane |
0.64% (1/157) |
8.39 |
0.002984 |
0.038535 |
| GO:0005840 |
ribosome |
4.46% (7/157) |
1.93 |
0.002604 |
0.038674 |
| GO:0099503 |
secretory vesicle |
0.64% (1/157) |
6.8 |
0.008926 |
0.04208 |
| GO:0030141 |
secretory granule |
0.64% (1/157) |
6.8 |
0.008926 |
0.04208 |
| GO:0097708 |
intracellular vesicle |
0.64% (1/157) |
6.8 |
0.008926 |
0.04208 |
| GO:0007218 |
neuropeptide signaling pathway |
0.64% (1/157) |
6.8 |
0.008926 |
0.04208 |
| GO:0031410 |
cytoplasmic vesicle |
0.64% (1/157) |
6.8 |
0.008926 |
0.04208 |
| GO:0031982 |
vesicle |
0.64% (1/157) |
6.8 |
0.008926 |
0.04208 |